Seeking AlphaMon, 08 Jun 2026 21:58:30 GMTAxsome Therapeutics, Inc. (AXSM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptAXSM+1.83%
MarketBeatSat, 06 Jun 2026 04:02:38 GMTAxsome Therapeutics Readies Auvelity Alzheimer's Agitation Launch, Expands CNS PipelineAXSM+1.83%
Zacks Investment ResearchWed, 03 Jun 2026 16:30:40 GMTWhy Is Axsome (AXSM) Down 0.4% Since Last Earnings Report?AXSM+1.83%
MarketBeatTue, 12 May 2026 22:08:15 GMTAxsome Therapeutics Bets on AUVELITY Expansion With June Alzheimer's Agitation LaunchAXSM+1.83%
Seeking AlphaTue, 12 May 2026 18:20:44 GMTAxsome Therapeutics, Inc. (AXSM) Presents at Bank of America Global Healthcare Conference 2026 TranscriptAXSM+1.83%
Zacks Investment ResearchTue, 05 May 2026 17:50:29 GMTAXSM Q1 Loss Widens, Revenues Jump on Higher Auvelity SalesAXSM+1.83%
Seeking AlphaMon, 04 May 2026 19:43:26 GMTAxsome Therapeutics, Inc. (AXSM) Q1 2026 Earnings Call TranscriptAXSM+1.83%
Seeking AlphaMon, 04 May 2026 16:32:32 GMTAxsome Therapeutics Q1 2026 Earnings Review: Gains Mystify Me, But Can't Be DeniedAXSM+1.83%
Zacks Investment ResearchMon, 04 May 2026 14:30:28 GMTHere's What Key Metrics Tell Us About Axsome (AXSM) Q1 EarningsAXSM+1.83%
Zacks Investment ResearchMon, 04 May 2026 13:15:27 GMTAxsome Therapeutics (AXSM) Reports Q1 Loss, Beats Revenue EstimatesAXSM+1.83%
Seeking AlphaFri, 01 May 2026 20:31:36 GMTAxsome Therapeutics, Inc. (AXSM) Discusses Approval of AUVELITY for Agitation Associated With Dementia Due to Alzheimer's Disease TranscriptAXSM+1.83%
Investors Business DailyThu, 30 Apr 2026 20:13:41 GMTAxsome Hits Record High On Alzheimer's Agitation ApprovalAXSM+1.83%
Zacks Investment ResearchThu, 30 Apr 2026 13:35:16 GMTPhathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Tops Revenue EstimatesAXSM+1.83%
Investors Business DailyThu, 16 Apr 2026 18:31:24 GMTBiotech Stock Knocks At $2 Billion Opportunity, Nears Buy PointAXSM+1.83%
